Home › Funds › RA CAPITAL MANAGEMENT, L.P. › COAG
RA CAPITAL MANAGEMENT, L.P. position in COAG
HEMAB THERAPEUTICS HOLDINGS · Health Care
RA CAPITAL MANAGEMENT, L.P. reported holding 7,808,627 shares of COAG (HEMAB THERAPEUTICS HOLDINGS) in its Q2 2026 13F filing — a position valued at US$286.8M, representing 2.49% of its reported portfolio and ranking #9 among its reported holdings. RA CAPITAL MANAGEMENT, L.P. first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How RA CAPITAL MANAGEMENT, L.P.'s COAG position evolved
RA CAPITAL MANAGEMENT, L.P. first disclosed a stake in COAG in Q2 2026 at 7,808,627 shares (US$286.8M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 7.81M | $286.81M | New |
About COAG and 13F data
COAG (HEMAB THERAPEUTICS HOLDINGS) is a Health Care company. 60 other funds we track also report a position in COAG — the largest reported positions include Novo Holdings A/S (US$153.6M), Deep Track Capital, LP (US$132.3M), Siren, L.L.C. (US$76.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding COAG
- Novo Holdings A/S 4.18M sh · $153.55M · Q2 2026
- Deep Track Capital, LP 3.60M sh · $132.30M · Q2 2026
- Siren, L.L.C. 2.09M sh · $76.65M · Q2 2026
- Avoro Capital Advisors LLC 1.93M sh · $70.71M · Q2 2026
- Bain Capital Life Sciences Investors, LLC 1.65M sh · $60.60M · Q2 2026
- Rock Springs Capital Management LP 575.43K sh · $21.14M · Q2 2026
- Opaleye Management Inc. 47.65K sh · $1.75M · Q2 2026
More on RA CAPITAL MANAGEMENT, L.P.
FAQ
How long has RA CAPITAL MANAGEMENT, L.P. held COAG?
RA CAPITAL MANAGEMENT, L.P. has disclosed COAG holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is RA CAPITAL MANAGEMENT, L.P.'s current position in COAG?
As of Q2 2026, RA CAPITAL MANAGEMENT, L.P. holds 7.81M shares of COAG (HEMAB THERAPEUTICS HOLDINGS), valued at $286.81M, representing 2.49% of its reported portfolio and ranking #9.
Has RA CAPITAL MANAGEMENT, L.P. been buying or selling COAG?
In the latest 13F filing (Q2 2026), RA CAPITAL MANAGEMENT, L.P. newly opened its position in COAG.
Which other funds hold COAG?
Other major institutional holders of COAG include Novo Holdings A/S, Deep Track Capital, LP, Siren, L.L.C., among 60 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.